|4Dec 5, 7:20 PM ET

CHANG LINDA L 4

4 · PHARMATHENE, INC · Filed Dec 5, 2012

Insider Transaction Report

Form 4
Period: 2012-12-03
CHANG LINDA L
SVP & CFO
Transactions
  • Award

    Stock Options (right to buy)

    2012-12-03+75,00075,000 total
    Exercise: $1.13Exp: 2022-12-03Common Stock (75,000 underlying)
Footnotes (2)
  • [F1]The options vest over a 4 year period with 25% each vesting on the first, second, third and fourth anniversaries of the grant date.
  • [F2]On December 3, 2012, the date such options were granted, the closing price of the Issuer's Common Stock on the NYSE Amex was $1.13 per share.

Documents

1 file
  • 4
    v329844_4.xmlPrimary

    OWNERSHIP DOCUMENT